Neoadjuvant chemotherapy in treatment of cervical cancer: Controversies

Bibliographic Details
Main Author: Mandić Aljoša
Format: Article
Language:English
Published: Institute of Oncology, Sremska Kamenica, Serbia 2005-01-01
Series:Archive of Oncology
Subjects:
Online Access:http://www.doiserbia.nb.rs/img/doi/0354-7310/2005/0354-73100502089M.pdf
_version_ 1818067669061992448
author Mandić Aljoša
author_facet Mandić Aljoša
author_sort Mandić Aljoša
collection DOAJ
first_indexed 2024-12-10T15:27:21Z
format Article
id doaj.art-01cd9b56760b4cb7aef66344ad9006a1
institution Directory Open Access Journal
issn 0354-7310
language English
last_indexed 2024-12-10T15:27:21Z
publishDate 2005-01-01
publisher Institute of Oncology, Sremska Kamenica, Serbia
record_format Article
series Archive of Oncology
spelling doaj.art-01cd9b56760b4cb7aef66344ad9006a12022-12-22T01:43:30ZengInstitute of Oncology, Sremska Kamenica, SerbiaArchive of Oncology0354-73102005-01-01132899010.2298/AOO0502089MNeoadjuvant chemotherapy in treatment of cervical cancer: ControversiesMandić Aljošahttp://www.doiserbia.nb.rs/img/doi/0354-7310/2005/0354-73100502089M.pdfcervix neoplasmsneoadjuvant therapytreatment outcome
spellingShingle Mandić Aljoša
Neoadjuvant chemotherapy in treatment of cervical cancer: Controversies
Archive of Oncology
cervix neoplasms
neoadjuvant therapy
treatment outcome
title Neoadjuvant chemotherapy in treatment of cervical cancer: Controversies
title_full Neoadjuvant chemotherapy in treatment of cervical cancer: Controversies
title_fullStr Neoadjuvant chemotherapy in treatment of cervical cancer: Controversies
title_full_unstemmed Neoadjuvant chemotherapy in treatment of cervical cancer: Controversies
title_short Neoadjuvant chemotherapy in treatment of cervical cancer: Controversies
title_sort neoadjuvant chemotherapy in treatment of cervical cancer controversies
topic cervix neoplasms
neoadjuvant therapy
treatment outcome
url http://www.doiserbia.nb.rs/img/doi/0354-7310/2005/0354-73100502089M.pdf
work_keys_str_mv AT mandicaljosa neoadjuvantchemotherapyintreatmentofcervicalcancercontroversies